ANL
Adlai Nortye Ltd. American Depositary SharesNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage ready
$11.76-17.33%
Close Oct 13, 2026
- Market cap
- —
- 1 month
- -26.2%
- 3 months
- +10.6%
- 1 year
- +648.7%
- 52-week range
- $0.88$16.60
- Dividend
- No dividends on record
- Short interest
- 9.3% of float4.4M shares · settled Sep 30, 2026 · -0.5% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if ANL is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
18 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: bearish
Last trade: sell 14 days ago
Red flags: 1
Largest 13-F holders · Q2 2026
42 filers reported a long position in ANL for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Cormorant Asset Management, LP | $45.7M | 4M | +37.3% |
| Venrock Adviser, LLC | $36.9M | 3.2M | Unchanged |
| BALYASNY ASSET MANAGEMENT L.P. | $35.2M | 3.1M | +248.8% |
| Point72 Asset Management, L.P. | $24.6M | 2.1M | New |
| MPM BioImpact LLC | $22.3M | 1.9M | New |
| PERCEPTIVE ADVISORS LLC | $20.6M | 1.8M | New |
| Casdin Capital, LLC | $14.4M | 1.3M | +132.1% |
| ADAR1 Capital Management, LLC | $11.7M | 1M | +763.2% |
| Octagon Capital Advisors LP | $10.7M | 934.7K | New |
| MILLENNIUM MANAGEMENT LLC | $9.3M | 807.8K | +18.5% |
Get the Full Analysis for ANL
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.